Answers are grounded in this paper and cite their sources.
Original article demonstrates diagnostic accuracy of CT-guided biopsy in pulmonary lesions, suggesting its utility for identifying underlying conditions.
in nodular lesions.The method facilitates diagnostic aspiration for microbiological cultures in cases of pulmonary infiltrates of unknown microbial etiology, helping identify pyogenic, mycobacterial, fungal, or opportunistic pathogens.Computed tomography-guided lung biopsy is regarded as a safe, minimally invasive procedure with established diagnostic accuracy.Among absolute contraindications, patient inability to cooperate (due to involuntary movement, coughing, or poor IntroductIonClinicians frequently face diagnostic difficulties when evaluating thoracic lesions, including localized infectious lesions and pulmonary, pleural, and mediastinal masses.Imaging results alone are frequently insufficient for establishing a conclusive diagnosis, even when clinical history, lesion size, and radiologic appearance aid in narrowing the differential diagnoses.Transthoracic needle biopsy (TTNB) guided by percutaneous computed tomography (CT) has emerged as the preferred method for assessing peripheral pulmonary lesions, particularly in cases when bronchoscopy is inefficient or nondiagnostic.CT guidance makes it possible to precisely target pulmonary nodules in almost any part of the thorax, which makes it incredibly useful for diagnostics.The assessment of suspected primary lung cancer, metastatic illness, and infections of uncertain etiology are the most frequent reasons for CT-guided biopsy of pulmonary lesions.In oncological settings, CT-guided TTNB enables genetic analysis of biopsy material and aids in establishing a histological diagnosis.For example, epidermal growth factor receptor (EGFR) mutations, which are essential for directing targeted therapy in patients with lung cancer, can be detected in core biopsy samples acquired under CT guidance. 1 Computed tomography (CT)-guided biopsy aids in distinguishing between benign and malignant processes 1,
No takes yet. Share an insight, caveat, or question.
Kona et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: